Dynamic coinfection with multiple viral subtypes in acute hepatitis C

Journal of Infectious Diseases

Volumn 202, Issue 12, 2010, Pages 1770-1779

  Smith, Jennifer A ^a   Aberle, Judith H ^d   Fleming, Vicki M ^b   Ferenci, Peter ^e   Thomson, Emma C ^c   Karayiannis, Peter ^c   McLean, Angela R ^a   Holzmann, Heidemarie ^d   Klenerman, Paul ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF VIENNA   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD;

ADOLESCENT; ADULT; AUSTRIA; CLONING, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

EID: 78650407546     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657317     Document Type: Article

References (44)

1. European Association for the Study of the Liver. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999; 31:3-8.
2. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46:423-441. (Pubitemid 20158079)
3. Harris KA, Gilham C, Mortimer PP, Teo CG. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol 1999; 58:127-131.
4. Micalessi MI, Gerard C, Ameye L, Plasschaert S, Brochier B, Vranckx R. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005. J Med Virol 2008; 80:640-645.
5. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18:352-358.
6. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107:2S-9S.
7. Cox AL, Page K, Bruneau J, et al. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology 2009; 136:26-31.
8. Heller T, Hoofnagle J, Liang TJ, Rehermann B. Acute hepatitis C. Gastroenterology 2009; 136:2411.
9. Farci P, Shimoda A, Coiana A, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 288:339-344.
10. Thimme R, Neumann-Haefelin C, Boettler T, Blum HE. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine. Biol Chem 2008; 389:457-467.
11. Farci P, Shimoda A, Wong D, et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996; 93:15394-15399. (Pubitemid 27009611)
12. Zibert A, Meisel H, Kraas W, Schulz A, Jung G, Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology 1997; 25: 1245-1249. (Pubitemid 27199955)
13. Korenaga M, Hino K, Katoh Y, et al. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J Viral Hepat 2001; 8:331-340.
14. Penin F, Combet C, Germanidis G, Frainais P-O, Deleage G, Pawlotsky J-M. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001; 75:5703-5710.
15. Aberle JH, Formann E, Steindl-Munda P, et al. Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 2006; 36:24-31.
16. Kuiken C, Combet C, Bukh J, et al. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 2006; 44:1355-1361.
17. Kuiken C, Simmonds P. Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 2009; 510:33-53.
18. Komurian-Pradel F, Perret M, Deiman B, et al. Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome. J Virol Methods 2004; 116:103-106.
19. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 2002; 30:3059-3066.
20. de Oliveira T, Deforche K, Cassol S, et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005; 21:3797-3800.
21. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599.
22. R Core Development Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2008.
23. Sheridan I. Analysis of immune escape and viral persistence in hepatitis C virus infection [doctoral thesis]. Nuffield Department of Clinical Medicine. Oxford, United Kingdom: University of Oxford, 2006:353.
24. Maggi F, Fornai C, Vatteroni ML, et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 1997; 78:1521-1525.
25. Ray SC,Wang Y-M, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 1999; 73: 2938-2946.
26. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 2004; 190: 1396-1403.
27. Li H, Thomassen LV, Majid A, et al. Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes. J Virol 2008; 82:7524-7532.
28. Schroter M, Feucht H-H, Zollner B, Schafer P, Laufs R. Multiple in fections with different HCV genotypes: prevalence and clinical impact. J Clin Virol 2003; 27:200-204.
29. Aitken C, McCaw R, Jardine D, et al. Change in hepatitis C virus genotype in injecting drug users. J Med Virol 2004; 74:543-545.
30. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat 2005; 12:322-324.
31. Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 2000; 28:21-25.
32. Chen YD, Liu MY, Yu WL, et al. Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in China. World J Gastroenterol 2003; 9:984-992.
33. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J Infect Dis 2007; 195:519-524.
34. Herring BL, Tsui R, Peddada L, Busch M, Delwart EL. Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol 2005; 79:4340-4346.
35. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982.
36. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965.
37. Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol 2004; 73:387-391.
38. Wietzke-Braun P, Mänhardt LR, Rosenberger A, Uy A, Ramadori G, Mihm S. Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates. World J Gastroenterol 2007; 13:4224-4229.
39. Harris HE, Eldridge KP, Harbour S, Alexander G, Teo C-G, Ramsay ME. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? J Viral Hepat 2007; 14:213-220.
40. Racanelli V, Rehermann B. Hepatitis C virus infection: when silence is deception. Trends Immunol 2003; 24:456-464. (Pubitemid 36928104)
41. Thimme R, Oldach D, Chang K-M, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:1395-1406.
42. Cox AL, Mosbruger T, Mao Q, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005; 201:1741-1752.
43. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 2001; 20:41-47.
44. Maieron A, Metz-Gercek S, Hackl F, et al. Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveillance 2010; 15:19492.